Formula Growth’s National Vision EYE Stock Holding History

Formula Growth’s Portfolio EYE Stock Details EYE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-31,300	Closed	-$811K	–	150
2026 Q1	$811K	Buy	+31,300	New	+$851K	0.37%	97

Other funds holding EYE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ECM

Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Formula Growth's EYE Position: Q2 2026 in Review

Formula Growth sold out of National Vision (EYE) in Q2 2026, closing a stake of 31,300 shares — an estimated $811K sold.

Formula Growth first reported a position in EYE in Q1 2026 and held it in 1 quarter. The position peaked at $811K in Q1 2026. 232 funds tracked by Wall St. Rank hold EYE as of Q2 2026.

Formula Growth reported no remaining National Vision position as of Q2 2026 after selling out during the quarter.
Formula Growth sold 31,300 National Vision shares in Q2 2026, an estimated $811K.
Formula Growth first reported a position in National Vision in Q1 2026 and held it in 1 quarter.
Formula Growth's National Vision position peaked at $811K in Q1 2026.
232 funds tracked by Wall St. Rank held National Vision as of Q2 2026.

Based on Formula Growth's 13F filing for Q2 2026, filed 17 Aug 2026.